Sun Pharma Q1 FY27 net profit rises 27% to ₹2,894.8 crore, revenue up 10.1% to ₹15,183.55 crore
Sun Pharmaceutical Industries reported a 27% year-on-year rise in consolidated net profit in Q1 FY27, while revenue grew 10.1% to ₹15,183.55 crore. India formulations sales climbed 16% to ₹5,474.9 crore and made up 36.1% of consolidated sales, while US revenue fell 9.7%. EBITDA increased 2.7% year on year to ₹4,417.7 crore, with a margin of 28.9%.